A simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens has been devised as a screening test for antibody in human sera. The test differs from our standard procedure by amalgamating 15 different immunotypes into nine antigen pools, by using only three serum dilutions, and by dropping use of' duplicate slides. The screening test could be performed on at least six times as many sera as the standard test for a given unit of eff'ort. It was shown to have a sensitivity equal to the standard test and an ability to determine specif'ic immunotype on the basis of antibody pattern (72%) only slightly reduced from the standard test (84%). The screening test was carried out on 876 patients from different population groups in the Seattle area.
A simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens has been devised as a screening test for antibody in human sera. The test differs from our standard procedure by amalgamating 15 different immunotypes into nine antigen pools, by using only three serum dilutions, and by dropping use of' duplicate slides. The screening test could be performed on at least six times as many sera as the standard test for a given unit of eff'ort. It was shown to have a sensitivity equal to the standard test and an ability to determine specif'ic immunotype on the basis of antibody pattern (72%) only slightly reduced from the standard test (84%). The screening test was carried out on 876 patients from different population groups in the Seattle area.
The tests showed that antibody was present frequently in persons attending venereal disease clinics (60%) and commonly (25%) in a group of adults without venereal disease. Nine percent of children under 15 years of age tested had antibody; the significance of this finding is unknown.
Knowledge of the pathogenesis, epidemiology, and control of'trachoma, inclusion conjunctivitis, lymphogranuloma venereum (LGV), and nongonococcal urethritis has been difficult to obtain because of' the lack of a sensitive and type-specific antibody test for the trachoma and lymphogranuloma venereum organisms of the Chlamydia trachomatis species. We believe that the recently developed microimmunofluorescence (micro IF) test with trachoma-LGV antigens (9, 10) meets this need (1, 3, 6, 7, 12, 13) . The test has not been simple to perform, mostly because of' the large number of' diff'erent antigens and the time required for fluorescence microscopy to interpret the antigen-antibody reactions. We have described 14 separate immunotypes of Trachoma-LGV antigens (8, 11, 14, 15) (9) . The origin and immunological typing of the prototype strains that we used as antigen have also been presented (8, 11, 14, 15) . In this study the strains listed below (abbreviated name) were used as antigen. All except the LGV strains and the type A strain were isolated in our laboratories. The strains were arranged into nine antigen pools as follows: (1) C/TW-3, "J"/UW-61, "J"/UW-36; (2) A/G-17; (3) B/TW-5; (4) E/UW-5, D/UW-3; (5) L,/440, L2/434; (6) L/UW-31, L3/404; (7) G/UW-27, F/UW-6; (8) given to evaluation of the quality and intensity of fluorescent staining at each of the dilutions. Staining is graded +, + +, and + + +, depending on intensity and uniformity of involvement of the elementary bodies. The reagents and methodology of the micro IF are similar to those previously described (13) .
We have previously shown that most Trachoma immunotypes cross-react to some extent with other types (4, 10, 11, 14) . For use in this study, we defined a type-specific reaction as one in which the pattern of reaction suggests a particular type (13, 15) . Such reactions are not often monotypic. Also, reaction patterns to the pooled antigens of very closely related types (CJ, ED, GF, and KL3) are considered type specific.
Sera from several different population groups were tested. Sera from persons under 15 years old were obtained from a group of children suffering from respiratory infection (2) and from children in the Seattle Virus Watch Study (5), who were included through the courtesy of John Fox. Sera from healthy adults without known venereal disease came from three sources: the Seattle Virus Watch; a group of pregnant women; and a group of males at the time of enrollment in the Group Health Cooperative of Puget Sound (average age, 26 years). For comparison with these adult sera, sera were tested from a large group of men and women attending the Seattle-King County VD clinics.
RESULTS
The purpose of the simplified technique for micro IF fluorescence antibody tests with Trachoma-LGV antigens was to allow a considerably larger number of sera to be tested and at the same time maintain adequate specificity and sensitivity. To be successful, putting 15 antigens into 9 pools should not result in failure to measure antibody against any known type, nor should the use of only three serum dilutions seriously reduce the ability of the test to indicate the infecting antigen type. A laboratory worker can process from 10 to 14 micro IF slides with 9 groups of antigen dots per day, including preparation of the slides and the microscopic evaluation of the fluorescent reactions. In our standard test with nine serum dilutions where duplicate slides are used, this would allow testing of five to seven sera a day per worker. With the simplified test where duplicates are not used, antigen groups contain 9 rather than 13 dots and three sera can be tested on each slide; 30 to 40 sera a day can be processed by an individual. The preparation of antigen and other reagents is not affected by the simplified technique, but more sera must be diluted.
As a first step in evaluating the screening test, sera from persons with proven Trachoma-LGV infections with all immunotypes except type A were tested. Details of the source of the sera have been presented as part of a recent publication concerning testing human serum with the micro IF technique (13) . Table 1 shows the results of the screening test and presents for comparison results obtained with the nine pooled antigens of the screening test but utilizing nine twofold serum dilutions as in the standard test. Also presented are results obtained in the standard micro IF test with 13 antigens (13) . The simplified technique resulted in no loss of sensitivity. This was true not only for the homologous antibody reactions but for the lower-titer antibody found against other types. The immunotype specificity of antibody in a few sera was made clearer by complete dilution. This was particularly true in two of the LGV sera in which very high antibody titers were found. We have previously pointed out that there is a limit to the type specificity that can be obtained from examining sera alone (4, 13) . It cannot be expected that ED, GF, KL3, and C "J" can be differentiated on the basis of serum antibody alone. Ba cannot be diagnosed from serum alone. It will either appear as B or as B + EDL. We still have very limited experience with serum from LGV infection. Those that we have examined from chronic LGV with bubos have had very high-titer multiple antibody response, predominantly of the B-EDL complex. The LGV antigens are "junior" and often measure antibody titers as high as those seen with E and D after infections with E or D. In general, close correlation between the standard test and the screening test can be expected (Table 1) . Table 2 shows a series of results from the screening test with sera from patients of the VD clinic. The sera shown in Table 2 had a variety of antibody patterns. Antibody titer increases were found in three of the pairs. Three sera in which a type-specific diagnosis could not be made with the dilutions studied are presented. The quantitation of the strength of the fluorescence reaction in serum at the 1:32 end point as shown by the + + and + + + reactions are occasionally used to determine type specificity. The apparent specific reaction to type A in the sera of patient U-109, who was born in Java, is a rare finding in our experience with sera from Seattle and Taiwan. Since we have never isolated this type, either from the few patients who have shown such an antibody response or from The frequency of' antibody in the normal groups was much lower than in those attending the VD clinics. The 200 adults were thought to be much less sexually promiscuous than those attending the VD clinic. Although the children tested were f'ree of' VD, many of' them were suffering from respiratory inf'ections. Five of' the 15 children with antibody had what appeared to be type A reactions. Otherwise, the antibody types found in the sera of all groups were approximately similar. Despite the fact that the sera were not tested beyond 1:32 in the screening test, it was possible to make type-specific diagnoses on 72% of the sera with antibody. Of 13 Trachoma-LGV antigens with human sera from 124 patients from whom a trachoma-LGV organism had been isolated and typed (13) . From that study and others (1, 3, 6, 7) , the usefulness of this technique for detecting antibody in human serum and tears has been established. The test is sensitive and type specific. The possibility of the occurrence of false-positive reactions is not yet understood. One of the reasons for testing the control sera in this study was to begin an evaluation of' the possibility of false-positive reactions.
The technique used for screening for antibody has been successf'ul. At least six times as many sera can be tested with the screening compared with the standard test. The sensitivity of the screening test appears to be similar to that of the standard test. There was surprisingly little reduction in the specificity since 72% of the sera with antibody could be assigned to an immunotype compared with 84% of sera with antibody from persons yielding trachoma-LGV isolates tested with the standard method (13) . The reduction in specif'icity seemed to be due entirely to the limited dilutions used, since the nine antigen pools used in the screening test represented about the extent of specificity in immunotyping that can be expected from serum alone. We believe that the effect of dropping the use of duplicate tests is seen primarily in loss of some precision in determining the exact titer of cross-reacting rather than homologous antibody since the qualitative judgment of cross-reactions is susceptible to different interpretation, and our standard procedure has called for two different observers to evaluate the duplicate slides.
With the sera used in these studies there was no evidence that utilization of LGV antigens added either to the number of' sera revealing antibody or to the type specif'icity. Both the LGV and the type A antigen are "junior" (10, 11) . They tend to cross-react with antibody of other types. We have had very little experience with proven infections with these agents and remain uncertain of' some of the reactions with these antigens.
The major disadvantage of the screening test remains the frequent failure to find the end point antibody titer. This may prevent demonstration of antibody titer rises, comparisons of severity, and evaluation of the effect of therapy. The screening test is perfectly adequate when the presence or absence of antibody is all that is sought, such as in serological epidemiology. It is most practical when only a low percentage of sera tested show antibody. These can then be retested with more serum dilutions if the antibody titer is desired.
We are exploring another approach to determining antibody titer without loss of the advantages of the simplified test. This consists of using greater than twofold serum dilutions. When three fourfold serum dilutions are used (1:8, 1:32, 1:128), more end points are determined without apparent loss of accuracy.
